Presidential Symposium [E]

Chair	Yoshiki Akatsuka (Designated professor, Department of Immunology, Nagoya University Graduate School of Medicine)
	Takanori Teshima (Department of Hematology, Hokkaido University Faculty of Medicine)
Speaker	Factors associated with outcomes of CD19 CAR-T cell immunotherapy for B cell malignancies. Cameron J. Turtle（University of Sydney, Camperdown, NSW, Australia）
	Real World Evidence for CD19-targeted CAR T-cell Therapy in malignant lymphoma Hideki Goto (Hokkaido University Hospital)
	Real world evidence of BCMA CAR-T therapy as the game changer for triple-class exposed RRMM Tadao Ishida (Japanese Red Cross Medical Center)
	CAR-T in myeloma: Advancing from Trials to the clinic Yi Lin (Hematology, The Mayo Clinic, Rochester, MN, USA)

Symposium1 [New development of HLA reserch in allogeneic hematopoietic cell transplantation]

Chair	Makoto Murata (Department of Hematology, Shiga University of Medical Science)
	Satoko Morishima (Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology, Second Department of Internal Medicine, Graduate School of Medicine, University of the Ryukyus)
Speaker	Immunogenetics of Allogeneic Transplantation Effie W. Petersdorf (Fred Hutchinson Cancer Center, Seattle, WA, USA)
	The HLA-B leader in HCT; keep in mind the Natural Killer cell perspective Minoru Kanaya (Blood Disorders Center, Aiiku Hospital, )
	Approach to the development of donor selection method based on functional analysis of mismatched HLA Takeshi Sugio (Stanford University, School of Medicine)
	The role of HLA expression in allogeneic hematopoietic stem cell transplantation Satoko Morishima (Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology, Second Department of Internal Medicine, Graduate School of Medicine, University of the Ryukyus)

Symposium2 [SOS/VOD]

Chair	Masao Ogata (Department of Medical Oncology and Hematology, Oita University Faculty of Medicine)
	Kimikazu Yakushijin (Medical Oncology and Hematology, Kobe University Hospital)
Speaker	Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients Mohty Mohamad (Sorbonne University, Saint-Antoine Hospital, Paris, France)
	Pathogenesis and Biomarkers for SOS Hirohisa Nakamae (Graduate School of Medicine, Osaka Metropolitan University)
	SOS/VOD diagnosis (assisted by ultrasonography) Kimikazu Yakushijin (Medical Oncology and Hematology, Kobe University Hospital)
	Current status of diagnosis and treatment of late onset SOS Shinsuke Takagi (Toranomon Hospital)

Symposium3 [E] [New findings elucidated by single cell analysis in gene-modified cell therapy and graft-versus-host disease」

Chair	Noriko Doki (Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital)
	Kazuaki Yokoyama (Department of Hematology/Oncology, Research Hospital, The Institute of Medical Science, The University of Tokyo)
Speaker	An NK-like CAR T cell transition in CAR T cell dysfunction Shunichiro Kuramitsu (Nagoya Medical Center)
	Multiomics analysis of CAR-T therapy persistence Kai Tan (Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA)
	Elucidating immune reconstitution after stem cell transplantation by single-cell multiomics analyses Daisuke Ennishi (Center for Comprehensive Genomic Medicine, Okayama University Hospital)
	Analysis of immune cells in GVHD using single-cell technology Georg Stary (Department of Dermatology, Medical University of Vienna, Vienna, Austria)

Symposium4 [Cell therapy: Industry-University-Government Collaboration]

Chair	Yoshiko Atsuta (Japanese Data Center for Hematopoietic Cell Transplantation)
	Koji Kato (Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science)
Speaker	Utilization of Registries in the Emerging Field of Cellular Therapies: Patterns of Care, Regulatory and Research in the Real World Setting Marcelo C. Pasquini (Department of Medicine, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, WI, USA)
	Current status and issues of CAR-T cell product in Japan Miki Nakamura (Pharmaceuticals and Medical Devices Agency)
	Emerging roles of industry, government and academia collaborations for developing CAR T therapy Nobuhiro Tsukada (Department of Hematology, Japanese Red Cross Medical Center)
	Academic collaboration; Achievements of the "CAR-T task force" established by JSTMCT Yasuyuki Arai (Kyoto University Hospital)
	CAR-T PMS Consortium (tentative) Kumi Miyagishima (Novartis Japan)

Symposium5 [Indications for allo-HSCT to acute leukemia from the point of view of pediatorics and internal medicine. - seamless HSCT from pediatrics to internal medicine]

Chair	Motohiro Kato (Department of Pediatrics, the University of Tokyo)
	Ken Ishiyama (Dept. Hematology, Kanazawa University Hospital)
Speaker	Indication of allogeneic stem cell transplantation for patients with AML: a pediatrician's view Daisuke Tomizawa (National Center for Child Health and Development)
	Indication of allogeneic HCT for ALL.: From the viewpoint of Pediatrics. Katsuyoshi Koh (Saitama Children's Medical Center, Department of Hematology/Oncology)
	Indications for hematopoietic stem cell transplantation for AML: from the viewpoint of physicians Kotaro Miyao (Anjo Kosei Hospital)
	The evolving role of hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia Etsuko Yamazaki (Clinical Laboratory Department, Yokohama City University Hospital)

Symposium6 [Chronic GVHD]

Chair	Yoshihiro Inamoto (National Cancer Center Hospital)
	Yuki Asano-Mori (Toranomon Hospital)
Speaker	New treatment options for chronic graft-versus-host disease Stephanie J Lee (Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA)
	Clinial and basic research in chronic ocular GVHD Yoko Ogawa (Keio University School of Medicine/Shinjuku City Eye Clinic)
	Diagnostic and therapeutic strategies for oral chronic GVHD Yoshihiko Soga (Okayama University Hospital)
	Case presentation Part I: Treatment and management of chronic GVHD Yuki Asano-Mori (Toranomon Hospital)
	Case presentation Part II: Nursing intervention for patient with chronic GVHD Rina Hino (Toranomon Hospital)

JSHCT-KSBMT Joint Symposium [Treatment of Multiple myeloma in a new era of CAR-T therapy]

Chair	Takanori Teshima (Department of Hematology, Hokkaido University Faculty of Medicine)
	Hee-Je Kim (Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea)
Speaker	CAR-T therapy for multiple myeloma in a routine clinical practice: Current status and issues Masaki Ri (Nagoya City University Hospital)
	Emerging Clinical and Research Questions in the era of CAR-T Cell Therapy for Multiple Myeloma Junya Kuroda (Kyoto Prefectural University of Medicine Graduate School of Medical Science)
	Marrow filtrating lymphocytes as a T cell source for CAR-T cells generation in multiple myeloma Sung-Hoon Jung (Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Hwasun, Jeollanamdo, Republic of Korea)
	Functional characterization of T cells in microenvironment of multiple myeloma - implications for immunotherapy Yoon Seok Choi (Department of Hematology, Ajou University School of Medicine, Suwon, Korea)

Workshop1 [AI / Machine Learning]

Chair	Seiya Imoto (The University of Tokyo)
	Junya Kanda (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)
Speaker	Effective information extraction from large-scale biomedical data enabled by AI/ML technologies Rui Yamaguchi (Aichi Cancer Center Research Institute)
	Possibility of data fusion of multiple data source based on population-based cancer registry Yuri Ito (Osaka Medical and Pharmaceutical University)
	Medical AI/Machine Learning: a clinical informatics perspective Hiroshi Okamura (Osaka Metropolitan University)
	Implementation of machine learning in the field of stem cell transplantation Junya Kanda (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)

Workshop2 [post-transplant cyclophosphamid haploidentical SCT and Cord blood transplantation]

Chair	Naoyuki Uchida (Department of Hematology, Toranomon Hospital)
	Junichi Sugita (Sapporo Hokuyu Hospital)
Speaker	Comparison of HLA haploidentical stem cell transplantation using steroid (steroid-haplo) and post-tr Kazuhiro Ikegame (Department of Hematology, Hyogo Medical University Hospital)
	Aiming to improve outcomes of PTCy-based HLA-haploidentical transplantation Takashi Tanaka (Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)
	Current status and unit selection of unrelated single-unit cord blood transplantation Takaaki Konuma (The Institute of Medical Science, The University of Tokyo)
	Selection of GVHD Prophylaxis and Conditioning for Cord Blood Transplantation Seitaro Terakura (Department of Hematology and Oncology)

Workshop3 [Propriety of HSCT after CD19 CAR-T therapy]

Chair	Yuhki Koga (Department of Perinatal and Pediatric Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan)
	Hideki Muramatsu (Department of Pediatrics, Nagoya University Graduate School of Medicine)
Speaker	Consolidative allogeneic stem cell transplantation after CD19CAR-T therapy for ALL Nobuhiro Nishio (Center for Advanced Medicine and Clinical Research, Department of Advanced Medicine / Department of Pediatrics, Nagoya University Hospital)
	Consideration of consolidative therapies after CAR-T cell therapy for ALL Hidefumi Hiramatsu (Graduate School of Medicine, Kyoto University)
	Who needs allogeneic hematopoietic cell transplant after CART-cell therapy? Hirotoshi Sakaguchi (National Center for Child Health and Development)
	Treatment choice for pediatric relapsed/refractory B-ALL in a single institute: HCT or CAR-T cells? Yuhki Koga Department of Perinatal and Pediatric Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan)

Workshop4 [Considering HSCT outcome originating from Japan]

Chair	Yasushi Hiramatsu (Japanese Red Cross Society Himeji Hospital)
	Masahide Yamamoto (Tokyo Medical and Dental University)
Speaker	Optimizing HCT for aplastic anemia and myelodysplastic syndromes in children Nao Yoshida (Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital)
	The impact of PFS24 achievement after stem cell transplantation Ayumi Fujimoto (Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research、Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Shimane University)
	Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Yu Akahoshi (Jichi Medical University Saitama Medical Center / Icahn School of Medicine at Mount Sinai)
	The role of NK-cell in allogenic HSCT indicated by large-scale registry data analysis Hisayuki Yokoyama (Department of Hematology, Tohoku University Graduate School of Medicine)

Pro・Con1 [What should we do for a successful "second" HSCT?]

Chair	Ken-Ichi Matsuoka (Department of Hematology and Oncology, Okayama University, Okayama, Japan)
	Akinori Nishikawa
Speaker	Takayoshi Tachibana (Kanagawa Cancer Center) Yasuyuki Arai (Kyoto University Hospital)
	Hisashi Yamamoto (Toranomon Hospital) Yuho Najima (Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital)

Pro・Con2 [Considering eligibility to HSCT]

Chair	Shingo Yano (The Jikei University School of Medicine)
	Tetsuya Nishida (Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital)
演者	Kohei Hosokawa (Kanazawa University Hospital) Tatsunori Goto (Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital)
	Sakiko Kitamura (Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology, Second Department of Internal Medicine, Graduate School of Medicine, University of the Ryukyus) Ayumu Ito (Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan)

Pro・Con3「Positioning of CAR-T and auto HSCT in DLBCL treatment]

Chair	Masashi Sawa (Anjo Kosei Hospital)
Speaker	Koji Izutsu (National Cancer Center Hospital)
	Koji Kato (Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science)

Educational Lecture 1

Speaker	Basic understanding and recent topics of HLA in allogeneic hematopoietic stem cell transplantation Satoko Morishima

Educational Lecture 2

Speaker	New Genome Technologies; from single cell to sptatial analysis Yutaka Suzuki (The University of Tokyo)

Educational Lecture 3

Speaker	High-resolution imaging reveals T cell signaling during treatment with ICIs or CARs Tadashi Yokosuka (Tokyo Medical University)

Educational Lecture 4

Speaker	Role of next-generation sequencing-based HLA typing in hematopoietic cell transplantation Tatsuo Ichinohe (Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University)

Educational Lecture 5

Speaker	Optimal pre-transplant conditioning regimen in the era of new molecular targeted therapies Hisashi Yamamoto (Toranomon Hospital)

Educational Lecture 6

Speaker	Treatment strategy and immune reconstitution against CMV reactivation following allo-HCT Hideki Nakasone (Division of Hematology, Jichi Medical University Saitama Medical Center)

Educational Lecture 7

Speaker	Update on the treatments of acute graft-versus-host disease Makoto Murata (Department of Hematology, Shiga University of Medical Science)

Educational Lecture 8

Speaker	Uncommon and challenging Infectious complications after hematopoietic stem cell transplantation Nobuyoshi Mori (St. Luke's International Hospital)

Educational Lecture 9

Speaker	How to perform Registry Studies using TRUMP data Yoshiko Atsuta (Japanese Data Center for Hematopoietic Cell Transplantation)

Educational Lecture 10

Speaker	Toward further improvement in outcomes with stem cell transplant Shin Mineishi (Professor and Director, Penn State Hershey Medical Center)

Educational Lecture 11

Speaker	Indications and role of post-transplant cyclophosphamide (tentative) Leo Luznik

Educational Lecture 12

Speaker	How to collaborate for CAR-T cell therapy in the region Yasushi Onishi (Tohoku University Hospital)

Educational Lecture 13

Speaker	APBMT - supporting local activities for HSCT and CT Minako Iida (Aichi Medical University School of Medicine, Department of Promotion for Blood and Marrow Transplantation)
	International Cooperation in Gene-Modified T-Cell Therapy - Experience in Thailand Yoshiyuki Takahashi (Professor and Chairman, Department of Pediatrics, Nagoya University Graduate School of Medicine)

Educational Lecture 14

Speaker	Role of maintenance therapy after allogeneic stem cell transplantation in FLT3-mutated AML Daigo Hashimoto (Department of Hematology, Hokkaido University Faculty of Medicine)

Educational Lecture 15

Speaker	Peripheral blood stem cell harvest from healthy donor Masayuki Hino (Osaka Metropolitan University)

Educational Lecture 16

Speaker	Current Activity of the Social Insurance Committee, JSTCT. Koji Nagafuji (Division of Hematology & Oncology, Department of Medicine, Kurume University School of Medicine)

Educational Lecture 17

Speaker	Hematopoietic cell transplantation in the era of COVID-19 Tetsuya Nishida (Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital)

Educational Lecture 18

Speaker	Recent advances in the diagnosis and treatment of chronic GVHD DavidB.Miklos (Dept. of Medicine; Division of BMT & Cell Therapy Stanford University, Stanford, California)

Care for patients' families

Chair	Mitsuko Mori (Federation of National Pubic Service Personnel Mutual Aid Associations Hamanomachi Hospital)
	Yoko Yamamoto (Nagoya University Hospital)
Speaker	introduction of family nursing and case study under covid-19 outbreak Yuka Asano (Rakuraku support center)
	What can be done to capture the needs of the patient's family? Toru Okabayashi (Toranomon Hospital)
	Challenges for fulfilling and satisfied discharge support for the patients and families after HCT. Chinatsu Kamei (Yamagata Unversity Hospital)
	Supporting "rich time" for children and families: Family care of community-based children's hospice Akemi Tsumura (Yokohama Children's Hospice Project)

Considering fertility treatment

Chair	Rie Tsuruta (Osaka Metropolitan University Hospital)
	Akiko Unesoko (Konan Kosei Hospital)
Speaker	Fertility Preservation Treatment and Pregnancy after Remission Mitsutoshi Yamada (Keio University)
	Difficulties in caring for patients with infertility and infertility-related psychological destress Noriko Yokota (Harasanshin Hospital)
	Nursing Support in Reproductive Medicine after Cancer Treatment Hiro Sakanaka (Keio University Hospital)

Chair	Hisayo Doi (Kobe University Hospital)
	Reiko Yamahana (National cancer center hospital east)
Speaker	Current Status of LTFU for HSCT patients in Japan Ayako Mori (National Cancer Center Hospital)
	Current Status of LTFU at Fred Hutchinson Cancer Center Denae K. Davis (Blood and Marrow Transplant Long Term Follow-Up, Fred Hutchinson Cancer Center, Seattle, WA)

Nursing Educational Lecture 1 [Introduction and explanation of the newly established "Position paper for Oral Management in HSCT"]

Speaker	Yoshihiko Soga (Okayama University Hospital)

Nursing Educational Lecture 2 [How to assess laboratory data for transplant nursing: The very basics]

Speaker	Seitaro Terakura (Department of Hematology and Oncology)

Supporting career development of LTFU staff

Chair	Chieko Indo (Toranomon Hospital)
	Maki Yokota (Jichi Medical University Hospital)
Speaker	Teaching is learning twice over Chisako Naito (Ehime University hospital)
	Upbringing and issues for long-term follow-up nurses after hematopoietic stem cell transplantation Yuki Sanjoba (Toranomon Hospital)
	Training of LTFU personnel from the perspective of nursing managers Mayumi Hirata (Osaka Matropolitan University Hospital)

Considering work style of HCTC

Chair	Shingo Yano Jikei (University School of Medicine)
	Yumiko Mizushima (Shiga University of Medical Science Hospital)
Commentator	Tatsuo Ichinohe (Department of Hematology and Oncology、Research Institute for Radiation Biology and Medicine, Hirohsima University)
Speaker	Current Status and Issues of Working Concurrently As a Transplant Coordinator and a Nurse Yukari Wada (Ishikawa Prefectural Central Hospital)
	Becoming HCTC from MSW About Constructing the transplantation support task at Hematology Department Yukiko Nishida (Social medical corporation Kriyushikai Hartlife Hospital)
	Establishment of a coordination system in the hospital and discipline for HCTC careers Satomi Yamanaka (Center for Transplantation and Cellular Therapy, Tokyo Saiseikai Central Hospital)

Protection of HSCT donors in coordination process

Chair	Namie Yamazaki(Sapporo Hokuyu Hospital)
	Kazue Mori(Kansai University of International Studies)
Speaker	Support for sibling who have a possibility to be transplant donor in the context of team approach. Motoi Anzai(Fukushima Medical University Hospital)
	Advocacy of adolescent and young adult donors/recipients:A word nurse perspective Yasuko Yoshimoto(Sapporo hokuyu hospital)
	Advocacy for the children in the selection of donors for HSCT Naoko Kakee (National Center for Child Health and Development)